search for books and compare prices
Adam C. Berger has written 12 work(s)
Search for other authors with the same name
displaying 1 to 12 | at end
show results in order: alphabetically | oldest to newest | newest to oldest
Cover for 9780309371124 Cover for 9780323359870 Cover for 9780309316057 Cover for 9780309304948 Cover for 9780309298216 Cover for 9780309294539 Cover for 9780309253949 Cover for 9780309220347 Cover for 9780309211048 Cover for 9780309157711 Cover for 9780309159548
cover image for 9780323359870
Product Description: This issue of Surgical Oncology Clinics of North America, edited by Adam Berger, is devoted to Melanoma. Articles in this issue include: Current Staging and Prognostic Factors in Melanoma; Melanoma Pathology; Surgical Treatment of Primary and Recurrent Melanoma; Sentinel Lymph Node Mapping and Its Importance for Melanoma in the 21st Century; Lymph Node Dissection for Stage 3 Melanoma; Metastasectomy for Stage IV Melanoma; Local/Injectional Therapies for Satellite and In-Transit Disease; Regional Therapies for In-Transit Disease; Role for Radiation Therapy in Melanoma; Update on Immunotherapy for Melanoma; Targeted Therapies in Melanoma; and Evidence for Long-Term Follow-up of Melanoma Patients...read more

Hardcover:

9780323359870 | Elsevier Science Health Science div, March 13, 2015, cover price $99.00 | About this edition: This issue of Surgical Oncology Clinics of North America, edited by Adam Berger, is devoted to Melanoma.

cover image for 9780309298216
Product Description: Many drug developers have examined new strategies for creating efficiencies in their development processes, including the adoption of genomics-based approaches. Genomic data can identify new drug targets for both common and rare diseases, can predict which patients are likely to respond to a specific treatment, and has the potential to significantly reduce the cost of clinical trials by reducing the number of patients that must be enrolled in order to demonstrate safety and efficacy...read more

Paperback:

9780309298216 | 1 edition (Natl Academy Pr, March 15, 2014), cover price $35.00 | About this edition: Many drug developers have examined new strategies for creating efficiencies in their development processes, including the adoption of genomics-based approaches.

cover image for 9780309294539
Product Description: The process for translating basic science discoveries into clinical applications has historically involved a linear and lengthy progression from initial discovery to preclinical testing, regulatory evaluation and approval, and, finally, use in clinical practice...read more
By Sarah H. Beachy (editor), Adam C. Berger (editor), Samuel G. Johnson (editor) and Steve Olson (editor)

Paperback:

9780309294539 | Natl Academy Pr, February 25, 2014, cover price $37.00 | About this edition: The process for translating basic science discoveries into clinical applications has historically involved a linear and lengthy progression from initial discovery to preclinical testing, regulatory evaluation and approval, and, finally, use in clinical practice.

cover image for 9780309253949
Product Description: The sequencing of the human genome and the identification of associations between specific genetic variants and diseases have led to an explosion of genomic-based diagnostic tests. These tests have the potential to direct therapeutic interventions, predict risk or onset of disease, or detect residual disease...read more

Paperback:

9780309253949 | Natl Academy Pr, June 27, 2012, cover price $35.00 | About this edition: The sequencing of the human genome and the identification of associations between specific genetic variants and diseases have led to an explosion of genomic-based diagnostic tests.

cover image for 9780309220347
Product Description: The initial sequencing of the human genome, carried out by an international group of experts, took 13 years and $2.7 billion to complete. In the decade since that achievement, sequencing technology has evolved at such a rapid pace that today a consumer can have his or her entire genome sequenced by a single company in a matter of days for less than $10,000, though the addition of interpretation may extend this timeframe...read more

Paperback:

9780309220347 | Natl Academy Pr, February 1, 2012, cover price $37.00 | About this edition: The initial sequencing of the human genome, carried out by an international group of experts, took 13 years and $2.

cover image for 9780309157711
Product Description: Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice...read more

Paperback:

9780309157711, titled "The Value of Genetic and Genomic Technologies: Workshop Summary" | Natl Academy Pr, December 31, 2010, cover price $29.00 | About this edition: Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large.

cover image for 9780309159548
Product Description: Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research...read more

Paperback:

9780309159548 | Natl Academy Pr, December 31, 2010, cover price $21.00 | About this edition: Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth.

displaying 1 to 12 | at end